Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Zhejiang Medicine Co Ltd.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Zhejiang Medicine Co Ltd
China Flag
Country
Country
China
Address
Address
Floor 3, Building A, Kechuangyuan, 398 Mahuan Road, Binhaixincheng, Shaoxing, Zhejiang 312366
Telephone
Telephone
+86-575-85211973 / 86043699 (API)
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

ARX305 is the only anti-CD70 ADC in active development that targets CD70, a protein that is overexpressed in a broad range of solid and hematologic tumors, giving it the potential to treat a range of liquid and solid tumor cancers, where CD70 is overexpressed.


Lead Product(s): ARX305

Therapeutic Area: Oncology Product Name: ARX305

Highest Development Status: Phase IProduct Type: Large molecule

Recipient: Ambrx Inc

Deal Size: $4.0 million Upfront Cash: Undisclosed

Deal Type: Agreement November 09, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY